Only adverse events related to hormonal effects and serious adverse events that occurred during chemotherapy with or without goserelin were routinely assessed, with assessment according to the Common ...
Goserelin is a gonadotropin-releasing hormone agonist for ovarian function suppression in the treatment of pre- and perimenopausal patients with breast cancer and for the preservation of ovarian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results